| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/17/2009 | CA2725654A1 Imidazolidine derivatives |
| 12/16/2009 | EP2133353A1 Novel adenine compound |
| 12/16/2009 | EP2133347A1 1-biarylazetidinone derivatives |
| 12/16/2009 | EP2133342A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
| 12/16/2009 | EP2133339A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 12/16/2009 | EP2133335A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 12/16/2009 | EP2133333A1 New azabicyclic derivatives, method of preparing same and pharmaceutical compositions containing them |
| 12/16/2009 | EP2133325A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 12/16/2009 | EP2133077A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 12/16/2009 | EP2133070A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 12/16/2009 | EP2132171A1 Novel crystal forms of pyrrolylheptanoic acid derivatives |
| 12/16/2009 | EP2131850A1 Extracts of aster koraiensis, and pharmaceutical composition and functional food comprising the same |
| 12/16/2009 | EP2131844A1 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 12/16/2009 | EP1940248B1 Use of a nutritional formulation for promoting catch-up growth |
| 12/16/2009 | EP1619180B1 CaSR ANTAGONIST |
| 12/16/2009 | EP1429602B1 Methods for treating disorders using plant extracts |
| 12/16/2009 | EP0848704B2 Form iii crystalline ¬r-(r*,r*) -2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-¬(phenylamino)carbonyl -1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 12/16/2009 | CN101605905A Method for glycosylation of flavonoid |
| 12/16/2009 | CN101605784A Aza-bridged-ring compound |
| 12/16/2009 | CN101605783A New N, N'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors |
| 12/16/2009 | CN101605782A 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular IKK inhibitors |
| 12/16/2009 | CN101605780A New 2, 4-dianilinopyrimidines, preparation thereof as drugs,pharmaceutical compositions and use thereof essentially as IKK inhibitors |
| 12/16/2009 | CN101605775A Substituted 3-phenyl-1-(phenylthienyl)propan-1-one and 3-phenyl-1-(phenylfuranyl)propan-1-one derivatives, and preparation and use of same |
| 12/16/2009 | CN101605769A Thiazole compound (as ppard) ligand and pharmaceutical, cosmetic and health food comprised thereof |
| 12/16/2009 | CN101605762A Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 12/16/2009 | CN101605757A (Indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity |
| 12/16/2009 | CN101605561A Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 12/16/2009 | CN101605538A Use of citrulline for treating undernutrition conditions |
| 12/16/2009 | CN101602811A Preparation method of cara eight sugar and application thereof |
| 12/16/2009 | CN101602768A Method for purifying sesamin and sesamolin |
| 12/16/2009 | CN101602756A Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 12/16/2009 | CN101602706A New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 12/16/2009 | CN101602685A Calcium-glutamate chelate synthesis method using shellfish processing waste as calcium source |
| 12/16/2009 | CN101602680A Naphthyl ethylamine derivative and preparation method thereof and application of naphthyl ethylamine derivative in preparing weight-reducing medicament |
| 12/16/2009 | CN101601854A Health care spirit |
| 12/16/2009 | CN101601840A Medicament for treating hepatolenticular degeneration |
| 12/16/2009 | CN101601823A Formula of bodybuilding fat-reducing hawthorn tea |
| 12/16/2009 | CN101601814A Chinese medicinal capsule for treating diabetes |
| 12/16/2009 | CN101601812A Nutrient capable of strengthening human immunity and protecting cells of heat, brain, liver, kidney, stomach and intestine |
| 12/16/2009 | CN101601810A Traditional Chinese medicine for curing diabetes |
| 12/16/2009 | CN101601794A Traditional Chinese medicine preparation for reducing glucose and removing thirst |
| 12/16/2009 | CN101601784A Preparation method of granules for quickly reducing blood fat |
| 12/16/2009 | CN101601780A Application of Chinese violet in resisting diabetes mellitus and preventing relative metabolic diseases |
| 12/16/2009 | CN101601760A Application of murraya jasminorage leaf total flavonoids in preparing medicaments for treating diabetes |
| 12/16/2009 | CN101601727A Thrombus-dredging wine drug |
| 12/16/2009 | CN101601726A Medicinal composition for reducing blood sugar |
| 12/16/2009 | CN101601685A Medicinal composition for reducing blood sugar and blood lipid and treating diabetes |
| 12/16/2009 | CN101601684A Medicinal composition for reducing blood sugar and blood lipid and treating diabetes |
| 12/16/2009 | CN101601683A Medicinal composition for reducing blood sugar and blood lipid and treating diabetes |
| 12/16/2009 | CN101601682A Medicinal composition for reducing blood sugar and blood lipid |
| 12/16/2009 | CN101601681A Medicinal composition for reducing blood sugar and blood lipid |
| 12/16/2009 | CN101601675A Pregnane steroids for use in the treatment of CNS disorders |
| 12/16/2009 | CN101601674A Pregnane steroids for use in the treatment of cns disorders |
| 12/16/2009 | CN101601647A Riboflavine sodium phosphate composition injection and preparation method thereof |
| 12/16/2009 | CN101601646A Nasal cavity drop for treating diabetes and preparation method thereof |
| 12/16/2009 | CN101601640A Cocoon sericin layer alcohol soluble substance and preparation method thereof |
| 12/16/2009 | CN101601470A Lucid ganoderma grain vinegar |
| 12/16/2009 | CN101601469A Health care medicinal liquor and preparation method thereof |
| 12/16/2009 | CN101601451A Natural five-color glucose-reducing herbal cuisine porridge and preparing method thereof |
| 12/16/2009 | CN100569798C GLP-1 derivative |
| 12/16/2009 | CN100569295C Vanadium tonic comprising anion exchange resin as carrier, their preparation method and uses |
| 12/16/2009 | CN100569281C Preparation and use of compositions for treating and preventing necrosis |
| 12/16/2009 | CN100569275C Oil-solvent extraction of ginger extract |
| 12/16/2009 | CN100569242C Pumpkin polysaccharide enteric coatel preparation |
| 12/16/2009 | CN100569239C A composite vitamine and its preparation method as well as application |
| 12/16/2009 | CN100569225C Anorectic agent and air regulator for diet |
| 12/16/2009 | CN100569114C Crocodile meat preparation and production process thereof |
| 12/16/2009 | CN100569110C Yan shouguo health food composition |
| 12/15/2009 | US7632951 Inhibitors of integrin ανβ6 |
| 12/15/2009 | US7632930 Oligosaccharide derivative |
| 12/15/2009 | US7632870 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
| 12/15/2009 | US7632858 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 12/15/2009 | US7632836 2-Morpholinoethyl ester of pivagabine; improved pharmacokinetic and therapeutic profiles; bioavailability; dosage; brain disorders; behavioral disorders; antidepressants; anxiolytic agents; neurodegenerative disorders; analgesics; eating disorders; antiarthritic agents; bipolar disorders; dysthymia |
| 12/15/2009 | US7632830 Lactam compounds and pharmaceutical use thereof |
| 12/15/2009 | US7632813 Administering N-(3-{2-[3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-tetrahydro-2H-pyran-4-ylpropyl)cycloheptanecarboxamideas an inhibitor and a type of parathyroid hormone to treat and/orprevent bone metabolic diseases |
| 12/15/2009 | US7632808 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system |
| 12/15/2009 | US7632518 Microencapsulated oil |
| 12/15/2009 | CA2601208C Method of preventing or treating type 1 diabetes by gene therapy with a secreted form of glutamic acid decarboxylase. |
| 12/15/2009 | CA2501820C Chitosan-containing polysaccharide, method for preparing the same and use thereof |
| 12/15/2009 | CA2422698C Indoline derivatives and their use as 5-ht2 receptor ligands |
| 12/15/2009 | CA2393437C Exo-s-mecamylamine formulation and use in treatment |
| 12/15/2009 | CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 12/15/2009 | CA2308604C Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
| 12/10/2009 | WO2009149317A2 Transmucosal delivery of therapeutic agents and methods of use thereof |
| 12/10/2009 | WO2009149258A2 Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| 12/10/2009 | WO2009149058A2 Modified release niacin formulations |
| 12/10/2009 | WO2009149056A2 Combinations of niacin and an oxicam |
| 12/10/2009 | WO2009148287A2 Novel α-iso-cubebene compound extracted from schisandra chinensis and composition containing the compound as active ingredient for preventing and treating inflammatory diseases |
| 12/10/2009 | WO2009148195A1 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same |
| 12/10/2009 | WO2009148004A1 Novel compound and pharmaceutical application of same |
| 12/10/2009 | WO2009147990A1 Novel isoxazole derivative |
| 12/10/2009 | WO2009147831A1 Method and pharmaceutical composition for treatment of mental disorders |
| 12/10/2009 | WO2009147229A1 Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| 12/10/2009 | WO2009147228A1 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism |
| 12/10/2009 | WO2009147221A1 Small molecule leptin receptor modulators |
| 12/10/2009 | WO2009147219A1 New compounds vii |
| 12/10/2009 | WO2009147218A1 Pharmaceutical combination |
| 12/10/2009 | WO2009147216A1 New pyridine derivatives as leptin receptor modulator mimetics |